BLFE — Biolife Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Biolife Sciences, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2010 November 30th	2011 November 30th	2012 November 30th	2020 November 30th	2021 November 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	10-K	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	U USG	U USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.005	0.003	0	0.035	0.017
Net Total Accounts Receivable
Net Total Receivables	0	0	—	—	—
Prepaid Expenses
Total Current Assets	0.005	0.003	0	0.072	0.077
Net Property, Plant And Equipment	0	0	0	0.195	0.117
Net Goodwill
Net Intangible Assets
Total Assets	0.239	0.003	0	0.267	0.194
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0	0.013	0.076	0.844	1.07
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.008	0.053	0.083	0.957	1.07
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.231	-0.05	-0.083	-0.69	-0.88
Total Liabilities & Shareholders' Equity	0.239	0.003	0	0.267	0.194
Total Common Shares Outstanding
Total Preferred Shares Outstanding